The new research by Heriot-Watt University has identified a way of targeting an enzyme called EPAC1

Janssen’s Ponvory accepted for use within NHS Scotland for adults RRMS patients

Updated Date: Tue, 02 Nov 2021 00:00:00 EDT

Updated Date: Tue, 02 Nov 2021 00:00:00 EDT

Updated Date: Tue, 02 Nov 2021 00:00:00 EDT

Updated Date: Tue, 02 Nov 2021 00:00:00 EDT

Updated Date: Tue, 02 Nov 2021 00:00:00 EDT

Johnson & Johnson scores reversal of landmark $465M opioid ruling in Oklahoma esagonowsky Tue, 11/09/2021 – 14:27

Exposure in utero to a drug used to prevent miscarriage can lead to an increased risk of developing […]

Artificial intelligence has become hugely more important in medicine. This is mainly due to the availability of ever […]